We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Synthetic Mini-Antibody Binds to and Neutralizes SARS-CoV-2

News   Nov 04, 2020

 
Synthetic Mini-Antibody Binds to and Neutralizes SARS-CoV-2

SARS-CoV-2’s ability to infect cells relies on interactions between the viral spike protein (magenta) and the protein ACE2 (blue), which is present on the surface of human cells. These interactions can be disrupted by sybodies (black) – synthetic mini-antibodies similar to those produced by camels and llamas. Credit: Rayne Zaayman-Gallant/EMBL.

 
 
Advertisement
 

RELATED ARTICLES

Key Questions and Answers About the UK's First Approved COVID-19 Vaccine

News

The UK government has announced that the COVID-19 vaccine BNT162b2 – developed by Pfizer and BioNTech – has been authorized for use. Here, we address some of the key questions you may have about this announcement.

READ MORE

New Lab-on-Chip Infection Test Could Enable Cheaper, Faster Portable Diagnostics

News

A tiny new silicon-based lab-on-chip test could pave the way for cheap handheld infectious disease testing. The chip, developed at Imperial College London and known as TriSilix, is a ‘micro laboratory’ which performs a miniature version of the polymerase chain reaction (PCR) on the spot.

READ MORE

"Perturb-Seq" Unravels Function of Autism Genes

News

New technology has been designed that can determine the function of different genes in different cells simultaneously. They look specifically at those involved in autism.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE